Breast cancer management in middle-resource countries (MRCs): Consensus statement from the Breast Health Global Initiative

Breast

Volumn 20, Issue SUPPL. 2, 2011, Pages

  Yip, Cheng Har ^a   Cazap, Eduardo ^b   Anderson, Benjamin O ^c,d   Bright, Kristin L ^e   Caleffi, Maira ^f   Cardoso, Fatima ^g,h   Elzawawy, Ahmed M ⁱ   Harford, Joe B ^j   Krygier, Gabriel D ^k,l   Masood, Shahla ^m   Murillo, Raul ⁿ   Muse, Ignacio M ^l   Otero, Isabel V ^j   Passman, Leigh J ^o   Santini, Luiz A ^o   da Silva, Ronaldo Corrêa Ferreira ^o,q   Thomas, David B ^d   Torres, Soledad ^p   Zheng, Ying ^q   Khaled, Hussein M ^r  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b SLACOM Sociedad Latinoamericana y del Caribe de Oncologia Medica   (Argentina)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^f HOSPITAL MOINHOS DE VENTO   (Brazil)

^g EUROPEAN SCHOOL OF ONCOLOGY   (Italy)

^h Champalimaud Cancer Center   (Portugal)

ⁱ International Campaign for Establishment and Development of Oncology Centers (ICEDOC)   (Egypt)

^j NATIONAL CANCER INSTITUTE   (United States)

^k HOSPITAL DE CLÍNICAS   (Uruguay)

^l National Breast Cancer Program   (Uruguay)

^m UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

ⁿ Instituto Nacional de Cancerología de Colombia   (Canada)

^o INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^p CLÍNICA LAS CONDES   (Chile)

^q SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^r CAIRO UNIVERSITY   (Egypt)

more..

Author keywords

Breast cancer; Early detection; Health care financing; Middle resource countries; Multidisciplinary services; Treatment

Indexed keywords

ANTHRACYCLINE DERIVATIVE; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CONSENSUS DEVELOPMENT; CULTURAL FACTOR; CYTOLOGY; DEVELOPING COUNTRY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; GEOGRAPHY; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY CONTROL;

EID: 79953065840     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2011.02.015     Document Type: Article

References (66)

1. World Bank Country classification 2009, The World Bank, [updated 2009; cited July 2010]. http://data.worldbank.org/about/country-classifications.
2. Ferlay J., Shin H., Bray F., Forman D., Mathers C., Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC cancer base no. 10 2008, International Agency for Research on Cancer, Lyon, France, Accessed July 2010. http://globocan.iarc.fr.
3. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24(14):2137-2150.
4. Curado M., Voti L., Sortino-Rachou A. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control 2009, 20(5):751-756.
5. Sankaranarayanan R., Swaminathan R., Brenner H., Chen K., Chia K.S., Chen J.G., et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010, 11(2):165-173.
6. Chia K.S., Du W.B., Sankaranarayanan R., Sankila R., Seow A., Lee H.P. Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer 2001, 93(1):142-147.
7. Yip C.H., Taib N.A., Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 2006, 7(3):369-374.
8. Omar S., Khaled H., Gaafar R., Zekry A.R., Eissa S., el-Khatib O. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediter Health J 2003, 9(3):448-463.
9. Schieber G., Baeza C., Kress D., Maier M. Financing health systems in the 21st century. Disease control priorities in developing countries 2006, 225-242. Oxford University Press/the World Bank, Washington, DC. 2nd ed. D. Jamison, J. Breman, A. Measham, G. Alleyne, M. Claeson, D. Evans (Eds.).
10. World Bank country economic classification 2010, [updated 2010; cited 2010 November 1]; Available from:. http://data.worldbank.org/about/country-classifications.
11. Xu K., Evans D.B., Carrin G., Aguilar-Rivera A.M., Musgrove P., Evans T. Protecting households from catastrophic health spending. Health Aff (Millwood) 2007, 26(4):972-983.
12. BHGI The Global Summit on International Breast Health: optimizing healthcare delivery 2010, Seattle, WA, [updated 2010; cited 2010 July]; Available from:. http://portal.bhgi.org/GlobalPortfolio/globalsummit/Pages/Program.aspx.
13. Anderson B.O., Yip C.H., Smith R.A., Shyyan R., Sener S.F., Eniu A., et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008, 113(8 Suppl.):2221-2243.
14. Anderson B.O., Braun S., Carlson R.W., Gralow J.R., Lagios M.D., Lehman C., et al. Overview of breast health care guidelines for countries with limited resources. Breast J 2003 May-Jun, 9(Suppl. 2):S42-S50.
15. Yip C.H., Anderson B.O. The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries. Expert Rev Anticancer Ther 2007 Aug, 7(8):1095-1104.
16. IAEA A silent crisis: cancer treatment in developing countries 2003, International Atomic Energy Agency, Vienna.
17. Okonkwo Q.L., Draisma G., der Kinderen A., Brown M.L., de Koning H.J. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008 Sep 17, 100(18):1290-1300.
18. Instituto Brasileiro de Geografia e Estatística (IBGE) PNAD 2008 2010, IBGE, Rio de Janeiro.
19. Passman L., Ramalho A., Tomazelli J., Abreu D.M., Dias B.K., Assis M., et al. SISMAMA - implementation of an information system for breast cancer early detection programs in Brazil. Breast 2011, 20(Suppl. 1). TBD.
20. Thomas D.B., Gao D.L., Ray R.M., Wang W.W., Allison C.J., Chen F.L., et al. Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 2002 Oct 2, 94(19):1445-1457.
21. Screening for breast cancer: recommendations and rationale. Ann Intern Med 2002 Sep 3, 137(5 Pt 1):344-346.
22. Duffy S.W., Tabar L., Vitak B., Warwick J. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?. Breast J 2006 Jan-Feb, (12 Suppl. 1):S91-S95.
23. Pisani P., Parkin D.M., Ngelangel C., Esteban D., Gibson L., Munson M., et al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer 2006 Jan 1, 118(1):149-154.
24. Mittra I., Mishra G.A., Singh S., Aranke S., Notani P., Badwe R., et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010 Feb 15, 126(4):976-984.
25. Jorgensen K.J., Gotzsche P.C. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009, 339. b2587.
26. Hujun LI. The plight of China's breast cancer screening program [cited July 2010]; Available from:. http://www.chinatoday.com.cn/ctenglish/se/txt/2009-03/30/content_188455.htm.
27. Bish A., Ramirez A., Burgess C., Hunter M. Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res. 2005 Apr, 58(4):321-326.
28. Facione N.C., Facione P.A. The cognitive structuring of patient delay in breast cancer. Soc Sci Med 2006 Dec, 63(12):3137-3149.
29. Wright S.V. An investigation into the causes of absconding among black African breast cancer patients. S Afr Med J 1997 Nov, 87(11):1540-1543.
30. Structural and cultural barriers to clinical diagnosis of locally advanced breast cancer (LABC) in a multiethnic cohort: findings from Mexico, South Africa, India, and the United States. Proceedings of the Congressionally Directed Medical Research Program and Department of Defense Breast Cancer Research Program's era of hope conference June 2008, Baltimore, Maryland, USA. K. Bright, R. Schneider, J.D. Goldberg, D.K. Vijaykumar, J. Apffelstaedt, M. Gutíerrez de la Barrera (Eds.).
31. Abdel-Fattah M., Zaki A., Bassili A., el-Shazly M., Tognoni G. Breast self-examination practice and its impact on breast cancer diagnosis in Alexandria, Egypt. East Mediterr Health J 2000 Jan, 6(1):34-40.
32. Bright K., Barghash M., Gutíerrez de la Barrera M., Schneider R.F., Formenti S.C. The role of health system factors in delaying final diagnosis and treatment of breast cancer in Mexico City. Breast 2011, 20(Suppl. 1). TBD.
33. Shyyan R., Sener S.F., Anderson B.O., Garrote L.M., Hortobagyi G.N., Ibarra J.A., et al. Guideline implementation for breast healthcare in low- and middle-income countries: diagnosis resource allocation. Cancer 2008 Oct 15, 113(8 Suppl.):2257-2268.
34. Masood S. The expanding role of pathologists in the diagnosis and management of breast cancer: worldwide excellence in breast pathology program. Breast J 2003 May-Jun, (9 Suppl. 2):S94-S97.
35. Vargas H.I., Anderson B.O., Chopra R., Lehman C.D., Ibarra J.A., Masood S., et al. Diagnosis of breast cancer in countries with limited resources. Breast J 2003 May-Jun, (9 Suppl. 2):S60-S66.
36. Stalsberg H., Awuah B., Ibarra J.A., Nsiah-Asare A. Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer 2008 Oct 15, 113(8 Suppl.):2338-2346.
37. Newman E.A., Guest A.B., Helvie M.A., Roubidoux M.A., Chang A.E., Kleer C.G., et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 2006 Nov 15, 107(10):2346-2351.
38. Henson D.E., Oberman H.A., Hutter R.V. Practice protocol for the examination of specimens removed from patients with cancer of the breast: a publication of the Cancer Committee, College of American Pathologists. Members of the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens from Patients with Breast Cancer. Arch Pathol Lab Med 1997 Jan, 121(1):27-33.
39. Park S., Bae J., Nam B.H., Yoo K.Y. Aetiology of cancer in Asia. Asian Pac J Cancer Prev 2008, 9(3):371-380.
40. Wilkinson N.W., Shahryarinejad A., Winston J.S., Watroba N., Edge S.B. Concordance with breast cancer pathology reporting practice guidelines. J Am Coll Surg 2003, 196(1):38-43.
41. Rhodes A., Jasani B., Barnes D.M., Bobrow L.G., Miller K.D. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems. J Clin Pathol 2000, 53(2):125-130.
42. Wolff A.C., Hammond M.E., Schwartz J.N., Hagerty K.L., Allred D.C., Cote R.J., et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25(1):118-145.
43. Masood S. The fine line between competency and quality performance in breast pathology: are we serving our patients right?. Breast J 2007, 13(5):441-442.
44. Tan Y.O., Han S., Lu Y.S., Yip C.H., Sunpaweravong P., Jeong J., et al. The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey. Cancer 2010.
45. Eniu A., Carlson R.W., El Saghir N.S., Bines J., Bese N.S., Vorobiof D., et al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer 2008 , 113(8 Suppl.):2269-2281.
46. Cazap E., Buzaid A.C., Garbino C., de la Garza J., Orlandi F.J., Schwartsmann G., et al. Breast cancer in Latin America: results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation expert survey. Cancer 2008, 113(8 Suppl.):2359-2365.
47. Bese N.S., Munshi A., Budrukkar A., Elzawawy A., Perez C.A. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008, 113(8 Suppl.):2305-2314.
48. WHO medicines: essential medicines June 2010 [updated June 2010; cited 2010 July]; Available from:. http://www.who.int/mediacentre/factsheets/fs325/en/index.html.
49. Anderson B.O., Cazap E. Breast health global initiative (BHGI) outline for program development in Latin America. Salud Publica Mex 2009, 51(Suppl. 2):s309-s315.
50. IOM Institute of Medicine of the National Academies Committee on Cancer Control in low- and middle-income countries. Cancer control opportunities in low- and middle-income countries 2007, The National Academies Press, Washington, DC.
51. Mills A., Ranson M. The design of health systems. International public health: diseases, programs, systems, and policies 2001, 530-540. Aspen Publication, Gaithersburg, Maryland. R. Black, M. Merson, A. Mills (Eds.).
52. Ministerio de Salud Publica y Dirección General de Salud. PRONACCAN, Plan Estratégico 2005-2010. Uruguay; March 2009.
53. World health statistics 2009. WHO library cataloguing-in-publication data 2009, World Health Organization. Department of Health Statistics and Informatics of the Information, Evidence and Research Cluster, France.
54. Silverstein M.J. The Van Nuys Breast Center: the first free-standing multidisciplinary breast center. Surg Oncol Clin N Am. 2000, 9(2):159-175.
55. Cataliotti L., De Wolf C., Holland R., Marotti L., Perry N., Redmond K., et al. Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer 2007, 43(4):660-675.
56. El Saghir N.S., El-Asmar N., Hajj C., Eid T., i Khatib S., Bounedjar A., et al. Survey of utilization of multidisciplinary management tumor boards in Arab countries. The Breast 2011, 10.1016/j.breast.2011.01.011.
57. Kapiteijn E., van de Velde C.J. Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002, 38(7):919-936.
58. Verleye L., Vergote I., Reed N., Ottevanger P.B. Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer-Gynecological Cancer Group (EORTC-GCG). Ann Oncol 2009, 20(10):1631-1638.
59. IAEA On-site visits to radiotherapy centres: medical physics procedures Quality Assurance Team for Radiation Oncology (QUATRO) 2007, International Atomic Energy Agency (IAEA), Vienna, Austria.
60. Instituto Nacional de Cancerología Recomendaciones para la detección temprana de cáncer de mama en Colombia 2006, INC, Guía de práctica clínica Bogotá.
61. Murillo R., Díaz S., Sánchez O., Perry F., Piñeros M., Poveda C., et al. Pilot implementation of breast cancer early detection programs in Colombia. Breast Care 2008, 3:29-32.
62. Kreps G.L., Sivaram R. Strategic health communication across the continuum of breast cancer care in limited-resource countries. Cancer 2008, 113(8 Suppl.):2331-2337.
63. Johnsson A., Tenenbaum A., Westerlund H. Improvements in physical and mental health following a rehabilitation programme for breast cancer patients. Eur J Oncol Nurs 2010.
64. Ganz P.A., Hahn E.E. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol 2008, 26(5):759-767.
65. Azenha G., Bass L.P., Caleff M.I., Smith R., Pretorius L., Durstine A., et al. The role of breast cancer civil society in different resource scenarios. Breast 2011, (Suppl. 1). (TBD).
66. Gotay C.C., Wilson M.E. Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract 1998, 6(1):31-37.